Kirkstall
Organ-on-a-chip flow cell culture systems for studying drug toxicity and disease in academic and pharma labs
Highlights
- Hiring1 open role
- New on EvolcAdded 2026-10-28
About Kirkstall
Kirkstall Ltd develops the Quasi Vivo organ-on-a-chip cell culture system, an interconnected dynamic flow system in which media circulates between modular chambers. The system is used to study drug toxicity and disease, and is offered with several chamber formats, including the QV600, QV900 and QV1200.
Customers are academic and pharmaceutical research laboratories. The company sells its products and contract research organisation services into the life-science research market, and also generates revenue from training events. Its website states that Quasi Vivo is used in over 100 labs worldwide.
Kirkstall was founded in 2000 and is headquartered in Barnsley, United Kingdom. It works with universities across Europe, including the University of Sheffield, Newcastle University and the University of Leeds. The company is recruiting a Sales and Marketing Manager to lead its sales and marketing function.
Product: Quasi Vivo dynamic flow cell culture system with modular chambers for organ-on-a-chip research, plus contract research services.
Jobs at Kirkstall (1)
Kirkstall is hiring for one role in sales.
Sales and Marketing Manager
New on Evolc
Companies hiring like Kirkstall
Leadership
- J. Malcolm Wilkinson · FounderSource: company website
More biotech & pharma companies
LabGenius
Machine-learning and automation platform for discovering therapeutic antibodies for biotechnology and pharmaceutical companiesNew on EvolcRemote-friendlyLario Therapeutics
Develops disease-modifying precision medicines for severe epileptic disorders and Parkinson's disease, startingYoung companyNew on EvolcLevicept
Develops a non-opioid biologic treatment for osteoarthritis pain for patients with painful joint diseaseNew on EvolcLGC Group
Reference materials, diagnostic quality controls and analytical standards for labs and life-science companiesNew on EvolcLibero Pharma
Develops transdermal naltrexone patches for patients with addiction, fibromyalgia and Crohn’s diseaseNew on EvolcLightcast Discovery
Single-cell functional screening platform for antibody and drug discovery teams in biotech and pharma researchNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Google Analytics 4
- Google reCAPTCHA
- WordPress
- jQuery
- nginx